Oxaliplatin-based first-line chemotherapy is associated with improved overall survival compared to first-line treatment with irinotecan-based chemotherapy in patients with metastatic colorectal cancer – Results from a prospective cohort study

Oxaliplatin-based first-line chemotherapy is associated with improved overall survival compared to first-line treatment with irinotecan-based chemotherapy in patients with metastatic colorectal cancer – Results from a prospective cohort study

Norbert Marschner,1 Dirk Arnold,2 Erik Engel,3 Ulrich Hutzschenreuter,4 Jacqueline Rauh,5 Werner Freier,6 Holger Hartmann,7 Melanie Frank,8 Martina Jänicke7 On behalf of the TKK Registry Group 1Praxis für Interdisziplinäre Onkologie und Hämatologie, 2Klinik f&am...

Full description

Bibliographic Details
Main Authors: Marschner N, Arnold D, Engel E, Hutzschenreuter U, Rauh J, Freier W, Hartmann H, Frank M, Jänicke M
Format: Article
Language:English
Published: Dove Medical Press 2015-04-01
Series:Clinical Epidemiology
Online Access:http://www.dovepress.com/oxaliplatin-based-first-line-chemotherapy-is-associated-with-improved--peer-reviewed-article-CLEP

Internet

http://www.dovepress.com/oxaliplatin-based-first-line-chemotherapy-is-associated-with-improved--peer-reviewed-article-CLEP

Similar Items